Skip to main content

Table 2 Oral medications before admission and upon discharge

From: Preliminary results of the acute Heart Failure registry in the DELTA region of Egypt (DELTA-HF): a database and a quality initiative project

 

Pre-admission, n = 220

Upon discharge, n = 180

Beta-blockers, %

24.5

50

ACE inhibitors, %

20.9

63.3

ARBs, %

10.9

13.3

MRAs, %

21.8

52.2

Digoxin, %

22.7

10.0

Diuretics, %

54.5

92.2

Ivabradine, %

9.1

17.7

Nitrates, %

21.8

20.0

Amiodarone, %

5.5

14.4

Non-dihydropyridine CCBs

1.8

1.1

Dihydropyridine CCBs, %

3.6

5.5

Statins, %

24.5

56.6

Warfarin, %

24.5

38.8

Aspirin, %

32.7

48.8

P2Y12 receptor inhibitor, %

13.6

28.8

  1. ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, MRA mineralocorticoid receptor antagonist, CCB calcium channel blocker